Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03148106

Hand Rehabilitation Study for Stroke Patients

Optimizing Peripheral Stimulation Parameters to Modulate the Sensorimotor Cortex for Post-stroke Motor Recovery.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out what are the best settings for applying electrical nerve stimulation over the skin for the short-term improvement of hand dysfunction after a stroke. The ultimate goal is to some day design an effective long-term training program to help someone recovery their ability to use their hands and function independently at home and in society. In order to know how to apply electrical nerve stimulation to produce a good long-term effect on hand dysfunction, the investigators first need to know how to make it work best in the short-term, and improve our understanding of for whom it works and how it works. The investigators will use a commercially available transcutaneous electrical nerve stimulation (TENS) unit to gently apply electrical nerve stimulation over the skin of the affected arm. This is a portable, safe and easy to use device designed for patients to operate in their homes.

Conditions

Interventions

TypeNameDescription
DEVICESomatosensory Electrical StimulationThe investigators will put adhesive electrodes on the affected arm and connect it to a device that will deliver a gentle electrical stimulation to the hand and arm. The stimulation will last for different amounts of time, depending on the stimulation condition. This can be 30 minutes twice a day (1 hour apart), 1 hour continuously, 2 hours continuously, or 3 hours continuously. The stimulation conditions will also vary in stimulation strength. It is normal that some people may feel a tingling sensation, while others may feel nothing.

Timeline

Start date
2017-04-04
Primary completion
2028-12-01
Completion
2028-12-01
First posted
2017-05-10
Last updated
2025-05-25

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03148106. Inclusion in this directory is not an endorsement.